Core Viewpoint - Appia Rare Earths & Uranium Corp. is set to resume exploration activities at its Alces Lake project in Saskatchewan during summer 2025, following a preparatory program in 2024 focused on camp maintenance and land surveying [1][2]. Exploration Plans - The upcoming exploration program will utilize targets identified from a high-resolution Airborne Gravity Gradiometer (AGG) survey, which underwent advanced 3D processing in late 2024 [2][3]. - The summer 2025 phase will commence with Mobile Metal Ion (MMI) soil sampling and ground gravity surveys, aimed at testing potential REE-bearing zones from the surface to depths of 500 meters [2][4]. Strategic Focus - The exploration season's objective is to identify and prioritize compelling drill targets that could lead to larger sources of REE mineralization at Alces Lake [3]. - The program will integrate processed AGG geophysical data with new MMI soil sampling and gravity surveys to strategically focus the drill campaign on deeper potential [3][4]. Technical Approach - The goal is to identify geochemical anomalies that correlate with gravity-magnetic-radiometric-defined anomalies, which are indicators of monazite-hosted REE mineralization [4]. - Known showings like the WRCB and Magnet Ridge Zones will serve as models to guide the exploration tools [4]. Company Overview - Appia Rare Earths & Uranium Corp. is a publicly traded Canadian company engaged in the rare earth element and uranium sectors, holding rights to significant exploration areas in Saskatchewan and Brazil [8]. - The company has 153 million common shares outstanding and 177 million shares fully diluted [9].

Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, June 12, 2025 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) announces that, further to its news release dated May 12, 2025 (the "Release"), it has filed an updated mineral resource estimate for its Condor gold project (the "Condor Project") titled: "Independent Technical Report for the Condor Project, Ecuador" (the "Technical Report"). The Technical Report is effective February 28, 2025 and was prepa ...

Medicus Pharma Ltd. to Present at 2025 Bio International ConventionCompany Executive Chairman & CEO to Provide Corporate Updates on June 17th 2025June 12, 2025 7:30 AM EDT | Source: Medicus Pharma Ltd.Philadelphia, Pennsylvania--(Newsfile Corp. - June 12, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the schedule of the presentation of Dr. Raza Bokhari, Executive Chairman and CEO, at 2025 Bio International Convention.Event DetailsDate: Tuesday, ...

Kick. Sports Nutrition BELVIDERE, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that its new Kick. Sports Nutrition line was named the 2025 Sports Nutrition Product of the Year by the prestigious Mindful Awards. The Mindful Awards honor standout companies and products across the consumer-packaged g ...

VANCOUVER, BC, June 12, 2025 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) has announced the filing of a final short form base shelf prospectus dated June 11 (the "Prospectus") in each of the provinces and territories of Canada together with a corresponding shelf registration statement on Form F-10 (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC"). The Prospectus qualifies the issuance of common shares, preferred shares, warrants to purcha ...

Capital structure streamlined and potential dilution from Series A Warrants eliminated ahead of key Phase 2 clinical milestonesNEW YORK and MELBOURNE, Australia, June 12, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, announces it has successfully canceled all remaining Series A Warrants pursuant to its letter agreements with the holders of the Series ...

Core Insights - America's Car-Mart, Inc. reported financial results for the fourth quarter and full year ended April 30, 2025, highlighting a period of transformation and groundwork for future growth [1][4]. Fourth Quarter Key Highlights - Total revenue increased by 1.5% to $370.2 million, driven by a 2.6% increase in sales volumes to 15,649 units and a 4.2% increase in interest income [6][11]. - Gross margin percentage improved by 90 basis points to 36.4%, attributed to optimization in vehicle pricing and procurement strategies [12][21]. - Net charge-offs as a percentage of average finance receivables improved to 6.9% from 7.3% [13][21]. - Diluted earnings per share rose to $1.26 compared to $0.06 in the previous year [6][31]. Full Year Key Highlights - Total revenue for the fiscal year was $1.4 billion, a slight decrease of 0.2% or $3.0 million from the previous year [6][33]. - Sales volumes decreased by 1.7% to 57,022 units, while interest income increased by 5.0% to $244.7 million [6][33]. - Gross margin percentage increased by 200 basis points to 36.7% [6][33]. - Net charge-offs as a percentage of average finance receivables improved to 25.9% from 27.2% [6][33]. - Active customer count increased by 2.4% to 104,682 [6][33]. Management Commentary - The President and CEO emphasized the company's agility and focus on long-term success, highlighting key accomplishments such as the expansion of the loan origination system and improvements in gross margins [4][19]. Financial Metrics - Interest expense decreased by 2.2%, while total collections increased by 3.7% to $714.1 million for the fiscal year [6][33]. - The allowance for credit losses improved to 23.25% from 25.32% year-over-year, reflecting favorable performance in contracts under enhanced underwriting standards [14][34]. - The company completed a term securitization transaction on May 29, 2025, issuing $216 million of asset-backed notes [19].

The feedback validates both the Fumed Silica Reactor and its process, while also helping identify key optimizations to enhance material quality ahead of the next phase testsMONTREAL, June 12, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to inform shareholders that it has received results from testing conducted on the material shipped last week ...

– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – 93% (41/44) and 89% (24/27) CRc observed in NPM1-m and KMT2A-r AML response-evaluable patients, respectively – – 71% (24/34) and 88% (14/16) CR measurable residual disease (MRD)-negativity observed among responding NPM1-m and KMT2A-r AML patients, respectively – – 96% (47/49) of NPM1-m and 88% (29/33) KMT2A-r AM ...

MONTREAL, June 12, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes all-electric plasma processes and sustainable solutions to support heavy industry in their energy transition, emission reduction, commodity security, and waste remediation efforts, announces today that further to its news release dated May 28, 2025, and further to today’s press release from Pyr ...